Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
These symptoms require immediate medical attention
Associations between provider specialty and use of follow-up testing among patients on preventive pharmacological therapy for urinary stone disease
POD01A, a short peptide formulation targeted against oligomeric alpha-synuclein, was safe and well tolerated in a phase 1 study and resulted in a substantial humoral immune response [111]
Available in tasty Lemon Flavour, making weight management and fitness goals enjoyable every day
2022 Jun 27;16:1963-1974
Research Applications Investigation of multi-receptor peptide signaling mechanisms Study of integrated metabolic signaling pathway interactions Analysis of peptidereceptor binding and pathway modulation Use in biochemical research models involving complex signaling systems Key Features High-purity lyophilized research peptide (99%) Synthetic multi-receptor tri-agonist peptide structure Stable molecular profile suitable for laboratory research Designed for controlled biochemical and metabolic signaling studies Content Compound: Retatrutide Form: Lyophilized powder Storage Information Store in a cool, dry place protected from light Refrigeration recommended for maximum stability Use within the recommended timeframe after reconstitution Research Use Only
US$ 21.79
US$ 29.59
US$ 28.55
US$ 26.74
US$ 22.47
US$ 23.57
US$ 26.56
US$ 22.23
